William Blair Downgrades Complete Genomic (GNOM) to Market Perform
Tweet
Share
E-mailGet Alerts GNOM Hot Sheet
Price: $66.48 +13.62%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 8
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 8
Join SI Premium – FREE
William Blair downgraded Complete Genomic (NASDAQ: GNOM) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Complete Genomic click here. For more ratings news on Complete Genomic click here.
Shares of Complete Genomic closed at $3.00 yesterday.
For an analyst ratings summary and ratings history on Complete Genomic click here. For more ratings news on Complete Genomic click here.
Shares of Complete Genomic closed at $3.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
- Citi Downgrades Cactus, Inc. (WHD) to Neutral
- RBC Capital Downgrades Temple & Webster Group Ltd (TPW:AU) to Sector Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
